Talk:Ciprofloxacin

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ciprofloxacin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

This is the talk page for discussing improvements to the Ciprofloxacin article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1: 180 days

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine: Translation Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Translation task force (assessed as High-importance).

Do I take for breakfast? 2001:5B0:4CD0:24F8:6463:D2B8:430C:4B8 (talk) 15:30, 10 March 2023 (UTC)[reply]

Contraindications, or where? ...and Aortic Rupture + other Fluoroquinolines

As of December, 2022, the FDA prescribing information for Cipro's boxed warning states:

Because fluoroquinolones, including CIPRO, have been associated with serious adverse reactions (5.1-5.16), reserve CIPRO for use in patients who have no alternative treatment options for the following indications:
- Acute exacerbation of chronic bronchitis (1.9)
- Acute sinusitis (1.11)^[1]

I'm not sure where these belong exactly; they sorta imply that any prescribing reason other than those two is a contraindication (the wording of the FDA's statements to prescribers is more harsh and flat out says not to use them unless death would result otherwise, but it doesn't seem like the right place to put them. It should probably be mentioned though, since these have effectively been relegated to use in people who won't survive without them and have one of two conditions (down from 3 listed earlier in 2022).
Also, Aortic dissection is listed as an effect reported to the FDA by the article right now, but in December, 2018, it was added as a rare side effect (although not to the boxed warning) so this should probably be updated in the article.^[2]
Finally, since these warnings were added across all fluoroquinolines prescribed to humans, all of the other articles relating to them need to be updated with current information. I'm not really active enough on here to take this on but someone dealing with the pharma pages more regularly might want to look into it. Some sort of "should be updated with developing information" might be warranted on these pages since the transition from boxed tendinitis warning to boxed "damage to nearly everything" was rapid; I'd be amazed if these were allowed to be prescribed outside of hospital settings much longer, honestly. A Shortfall Of Gravitas (talk) 17:30, 24 May 2023 (UTC)[reply]

References

^ "Highlights of Prescribing Information" (PDF). FDA. 2022.
^ "FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients". FDA. December 20, 2018.

[1] "Highlights of Prescribing Information" (PDF). FDA. 2022.

[2] "FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients". FDA. December 20, 2018.

[1]

[2]